blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2512420

EP2512420 - USE OF 2,3-DIHYDROXYPROPYL DODECANOATE FOR TREATING SEBORRHEA [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  02.08.2019
FormerGrant of patent is intended
Status updated on  26.03.2019
FormerExamination is in progress
Status updated on  27.02.2019
FormerGrant of patent is intended
Status updated on  28.10.2018
FormerExamination is in progress
Status updated on  22.11.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Pierre Fabre Dermo-Cosmétique
45, place Abel Gance
92100 Boulogne-Billancourt / FR
[2019/36]
Former [2012/43]For all designated states
Pierre Fabre Dermo-Cosmétique
45, place Abel-Gance
92100 Boulogne-Billancourt / FR
Inventor(s)01 / DECHELETTE, Corinne
Les Genêts - Hameau de St Géry
F-81800 Rabastens / FR
02 / REDOULES, Daniel
42 avenue Etienne Billières
F-31300 Toulouse / FR
 [2012/43]
Representative(s)Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[2012/49]
Former [2012/43]Ahner, Francis, et al
Cabinet Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
Application number, filing date10792933.317.12.2010
[2019/36]
WO2010EP70028
Priority number, dateFR2009005916518.12.2009         Original published format: FR 0959165
[2012/43]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO2011073370
Date:23.06.2011
Language:FR
[2011/25]
Type: A2 Application without search report 
No.:EP2512420
Date:24.10.2012
Language:FR
The application published by WIPO in one of the EPO official languages on 23.06.2011 takes the place of the publication of the European patent application.
[2012/43]
Type: B1 Patent specification 
No.:EP2512420
Date:04.09.2019
Language:FR
[2019/36]
Search report(s)International search report - published on:EP19.07.2012
ClassificationIPC:A61K31/215, A61Q19/00, A61K8/37
[2018/43]
CPC:
A61Q19/008 (EP,KR,US); A61K31/56 (KR); A61K8/375 (EP,CN,KR,US);
A61K31/23 (EP,CN,US); A61K35/08 (EP,US); A61K45/06 (EP,US);
A61K47/02 (EP,US); A61K47/10 (EP,US); A61K47/14 (EP,US);
A61K47/32 (EP,US); A61K8/63 (KR); A61K8/67 (KR);
A61K9/0014 (EP,US); A61K9/06 (EP,US); A61K9/107 (EP,US);
A61P17/00 (EP); A61P17/08 (EP); A61Q19/00 (CN);
A61Q5/12 (CN); A61K2800/75 (CN) (-)
C-Set:
A61K35/08, A61K2300/00 (EP,US)
Former IPC [2012/43]A61K8/37, A61Q19/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/43]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERWENDUNG VON 2,3-DIHYDROXYPROPYL-DODECANOAT ZUR BEHANDLUNG VON SEBORRHÖ[2012/43]
English:USE OF 2,3-DIHYDROXYPROPYL DODECANOATE FOR TREATING SEBORRHEA[2012/43]
French:UTILISATION DU 2,3-DIHYDROXYPROPYL DODÉCANOATE POUR LE TRAITEMENT DE LA SÉBORRHÉE[2012/43]
Entry into regional phase18.07.2012National basic fee paid 
18.07.2012Designation fee(s) paid 
18.07.2012Examination fee paid 
Examination procedure18.07.2012Examination requested  [2012/43]
28.01.2013Amendment by applicant (claims and/or description)
07.08.2015Despatch of a communication from the examining division (Time limit: M04)
04.12.2015Reply to a communication from the examining division
11.11.2016Despatch of a communication from the examining division (Time limit: M04)
17.03.2017Reply to a communication from the examining division
29.01.2018Despatch of a communication from the examining division (Time limit: M04)
13.02.2018Reply to a communication from the examining division
29.10.2018Communication of intention to grant the patent
26.02.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
27.03.2019Communication of intention to grant the patent
25.07.2019Fee for grant paid
25.07.2019Fee for publishing/printing paid
25.07.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.08.2015
Opposition(s)05.06.2020No opposition filed within time limit [2020/33]
Fees paidRenewal fee
22.11.2012Renewal fee patent year 03
22.11.2013Renewal fee patent year 04
26.11.2014Renewal fee patent year 05
27.11.2015Renewal fee patent year 06
30.11.2016Renewal fee patent year 07
29.11.2017Renewal fee patent year 08
29.11.2018Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.12.2010
AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
MK04.09.2019
MT04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
TR04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IE17.12.2019
LU17.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
IS05.01.2020
[2022/31]
Former [2022/26]HU17.12.2010
AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
MT04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
TR04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IE17.12.2019
LU17.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
IS05.01.2020
Former [2021/34]HU17.12.2010
AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
MT04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IE17.12.2019
LU17.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
IS05.01.2020
Former [2021/32]HU17.12.2010
AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IE17.12.2019
LU17.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
IS05.01.2020
Former [2021/26]AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IE17.12.2019
LU17.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
IS05.01.2020
Former [2020/51]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IE17.12.2019
LU17.12.2019
BE31.12.2019
CH31.12.2019
LI31.12.2019
IS05.01.2020
Former [2020/46]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IE17.12.2019
LU17.12.2019
IS05.01.2020
Former [2020/39]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
Former [2020/37]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
Former [2020/36]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
Former [2020/27]AL04.09.2019
AT04.09.2019
CZ04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS24.02.2020
Former [2020/25]AL04.09.2019
AT04.09.2019
CZ04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS24.02.2020
Former [2020/23]AL04.09.2019
AT04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/22]AL04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/20]AL04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/15]AL04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/11]FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/10]FI04.09.2019
LT04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
Former [2020/09]FI04.09.2019
LT04.09.2019
NO04.12.2019
Former [2020/08]LT04.09.2019
NO04.12.2019
Cited inInternational search[XY]US4921694  (HOPPE UDO [DE], et al) [X] 5-9 * claims 1-6 * [Y] 10,11;
 [XY]US6110908  (GUTHERY B EUGENE [US]) [X] 5-9 * claims 1-9 * * table VII * [Y] 10,11;
 [A]FR2867973  (B PRINCE SARL LAB [FR]) [A] 1-12 * page 1, line 15 - line 19; claims 1,2 * * page 2, line 12 - line 15 ** claims 1-7 *;
 [Y]US2009203628  (MARINI JAN [US]) [Y] 1-12 * paragraph [0030] * * paragraph [0040] * * example 2 * * claims 1,2 *;
 [Y]  - NIEDERPRUEM H-J ET AL, "INHIBITION OF STEROID 5ALPHA-REDUCTASE ACTIVITY BY ALIPHATIC FATTY ACIDS CANDIDATES FOR CHEMOPREVENTION OF PROSTATE CANCER", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, NEW YORK ACADEMY OF SCIENCES, NEW YORK, NY, US LNKD- DOI:10.1111/J.1749-6632.1995.TB12127.X, (19950101), vol. 768, ISSN 0077-8923, pages 227 - 230, XP000949291 [Y] 1-12 * page 229 *

DOI:   http://dx.doi.org/10.1111/j.1749-6632.1995.tb12127.x
by applicant   - LUU-THE ET AL., "Characterization, Expression and Immunohistochemical localization of 5-alpha reductase in human skin", THE JOURNAL OF INVESTIGATE DERMATOLOGY, (1994), doi:doi:10.1111/1523-1747.ep12371766, pages 221 - 226, XP000570344

DOI:   http://dx.doi.org/10.1111/1523-1747.ep12371766
    - LUU-THE ET AL., "haracterization, Expression and Immunohistochemical localization of 5-alpha reductase in human skin", THE JOURNAL OF INVESTIGATE DERMATOLOGY, (1994), pages 221 - 226
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.